Purchase Order 75N92023P00366
Award Date 9/26/23
Potential Completion Date 9/23/24
Potential Value $171K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Albuquerque, NM 87108, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed price delivery order for $24,990 was awarded by the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute to Lovelace Biomedical Research Institute. The order was issued against the GSA Schedule for Professional and Allied Healthcare Staffing Services and requires a mouse study of smoking to further the research aims of the Levy Lab at NIH/NHBLI/PSB regarding developing therapeutic targets. The study is to be completed by...
- This contract was awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), to the Lovelace Biomedical Research Institute. The $16,653 firm-fixed-price purchase order is for pulmonary function testing to determine if the Flexivent method is suitable for use in a larger NHLBI study. The award does not have a set-aside designation. Lovelace Biomedical Research Institute is a not-for-profit preclinical contract research...
- This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a subsidiary of Lovelace Biomedical Research Institute. The $203,807.96 contract is a delivery order for Task Area A under the Pharmacology-Toxicology Core Lab task order 7 of the NHLBI's Gene Therapy Resource Program (GTRP). The work, which has no set-aside designation,...
- This is a federal contract award to Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization, by the National Heart Lung and Blood Institute (NHLBI). The $1,609,194.07 contract is a Delivery Order under the Gene Therapy Resource Program (GTRP) to provide pharmacology/toxicology core laboratory services for a scientific project. This work supports the National Institutes of Health's research efforts in gene therapy. The contract does not have a set-aside...
- This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to the Lovelace Biomedical Research Institute. The $1,143,792.16 cost-plus-fixed-fee contract is for the GENE THERAPY RESOURCE PROGRAM (GTRP) and calls for the awardee to provide a Pharmacology and Toxicology Core Laboratory. The contract does not have a set-aside designation. Lovelace Biomedical Research Institute is a not-for-profit...
- This is a $507,702.77 cost-plus-fixed-fee delivery order contract awarded by the National Heart, Lung, and Blood Institute (NHLBI) to the Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The contract supports the NHLBI's Gene Therapy Resource Program (GTRP) by providing resources and services from three core laboratories focused on pharmacology and toxicology, preclinical vector development, and a clinical coordinating center. This contract...
- This federal contract award, valued at $1,013,722.26, was issued by the National Heart Lung and Blood Institute, a civilian agency, to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a not-for-profit contract research organization. The award is for the GTRP Pharmacology-Toxicology Core Lab, Task Order 6, Task Area B, with a period of performance through April 15, 2017. The contract is a cost-plus-fixed-fee delivery order, without a set-aside designation. LBERI, a...
- This is a cost-plus-fixed-fee task order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Heart Lung and Blood Institute to Lovelace Biomedical Research Institute, a not-for-profit contract research organization. The $352,485.43 task order is for pharmacology/toxicology core laboratory services in support of the Gene Therapy Research Program (GTRP). It does not have a set-aside designation. Lovelace Biomedical has a history of serving as a...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $716,374 delivery order contract to Lovelace Biomedical Research Institute. Under the terms of the firm fixed price contract, Lovelace Biomedical Research Institute will conduct a Good Laboratory Practice repeat dose toxicology study for BPL-24910 in support of the Comprehensive and Rapid Response for NIAID Research Programs major program code. Performance...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $163,000 cost-plus-fixed-fee delivery order contract to Lovelace Biomedical Research Institute. The contract is for the assessment of potential treatments for drug-induced respiratory depression and overdose toxicity under Task Order 75N95022F00002 of an unspecified multiple award contract vehicle. Lovelace will conduct the assessment from September 2022 through September 2024...